# SGS North America Inc. – FDA Inspection, Jun 9, 2026

Source: https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/19f7bf6c-95d5-4ab7-b207-dd53edeedef6
Source feed: FDA_Inspections

> FDA inspection 1321138 of SGS North America Inc., June 09, 2026. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1321138
- Company Name: SGS North America Inc.
- Inspection Date: 2026-06-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1211177 - 2023-08-01](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/c6f19e1c-ac16-4775-b564-beda8746d962)
- FDA Inspection 1027721 - 2017-08-30
- [FDA Inspection 973286 - 2016-06-07](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/4e004227-2261-4022-b159-d244067595d6)
- [FDA Inspection 862181 - 2014-01-21](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/7be923bd-27ee-433c-9070-d1f7d294e919)
- FDA Inspection 753526 - 2011-11-21

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/janet-a-rajan/95741927-9a4d-422b-bd51-01783d962cbe)
- [Investigator](https://www.keypedia.com/people/stephenie-m-ortiz/b0923b14-b153-4893-8eb2-f5e6b1fd2041)
- [Investigator](https://www.keypedia.com/people/suchan-kim/1acf9a36-036f-48a8-a8a4-caa290830e37)

Company: https://www.keypedia.com/companies/sgs-north-america-inc/2ab4b437-f0ec-4f38-a8bc-88a319e32f4d

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248